BCR/ABL Oncogene Directly Controls MHC Class I Chain-Related Molecule A Expression in Chronic Myelogenous LeukemiaNicolas Boissel, Antoine Toubert, Vannary Tieng et al.|The Journal of Immunology|2006Cited by 142
Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey ModelsThierry Menguy, Philippe Le Bouteiller|Investigative Ophthalmology & Visual Science|2018Cited by 10